Assessing the performance of a new diagnostic criterion for diagnosing esophageal lichen planus Authors: Anwesh Dash, Alexandra Strauss Starling, Sydney Shaffer, Amanda Muir, Kristle L Lynch Published: 2026 ABSTRACT AbstractEsophageal lichen planus (ELP) is a unique manifestation of lichen planus that is rarely studied. This disorder presents diagnostic challenges due to variable clinical presentations and the absence of universally accepted diagnostic criteria. This study evaluates the performance of the Schauer Diagnostic Criteria (SDC) in diagnosing ELP for two specific cohorts: patients with extra-esophageal manifestations of lichen planus (LP) and patients without extra-esophageal manifestations of LP. We analyzed esophageal biopsies with lichenoid patterns from a tertiary care center. We calculated the SDC scores using endoscopy and pathology reports in patients with extra-esophageal LP (17 patients, 43 specimens) and patients without extra-esophageal lichen planus (60 patients, 84 specimens). We then reviewed gastroenterology clinic notes for these patients to assess the performance of the SDC in correctly diagnosing ELP for these cohorts. The SDC demonstrated high concordance with gastroenterologists in diagnosing ELP in patients with extra-esophageal LP. Meanwhile, the SDC had higher discordance with gastroenterologists for patients without any extra-esophageal LP, suggesting that ELP is likely underdiagnosed clinically for this cohort of patients. Key endoscopic findings included mucosal pallor and sloughing, while histologically, lymphocytic infiltration and dyskeratosis were common across all specimens. Our findings support the utility of SDC in both patient cohorts. Our study validates the SDC for the study’s original patient population: patients with prior extra-esophageal lichen planus. In patients without prior extra-esophageal lichen planus, our study demonstrates the utility of SDC and points to some potential missed or delayed diagnoses. For patients with high suspicion, widespread use of this diagnostic tool could standardize the diagnosis of this under-recognized condition.Keywords: esophageal diseases, esophageal motility, esophageal strictures, esophageal dysmotility, esophagology INTRODUCTION Lichen planus (LP) is a chronic inflammatory disease of unknown etiology that affects both skin and mucosal surfaces. Its global prevalence varies, with the fewest cases noted in North America (0.47%) and Asia (0.83%) and peaking in South-Central America (1.74%) and Europe (1.32%).1,2 Esophageal lichen planus (ELP), a common cause for dysphagia in patients with LP, was traditionally considered rare with a prevalence around 0.19% among patients with cutaneous LP.3,4 However, endoscopic evaluation is not universal in patients with LP, and recent evidence suggests that esophageal involvement may be more common than previously thought, with up to 50% of patients with cutaneous or oral LP potentially having esophageal manifestations.5,6 The diagnosis of ELP relies on both endoscopic and histopathologic features. Classic endoscopic findings include esophageal mucosal denudation or sloughing, while histology most often reveals lymphocyte infiltrates, intraepithelial apoptosis, and epithelial detachment.7 These features often overlap with other inflammatory esophageal conditions, making this multifaceted diagnosis quite challenging. Moreover, emerging data indicate that ELP can occur independently of cutaneous involvement, further complicating its recognition.8 Diagnosis of ELP in patients without any extra-esophageal manifestations has been difficult, leading to underdiagnosis and delayed management. A distinct scoring system has been developed to address these diagnostic challenges: the Schauer Diagnostic Criteria (SDC).8 As shown in Table 1, the SDC integrates endoscopic denudation features with histopathologic criteria such as epithelial detachment, lymphocytic infiltration, Civatte bodies, and dyskeratosis, serving as the first well-defined diagnostic tool for ELP. Table 1Schauer Diagnostic CriteriaSDCSevere ELPEndoscopy ≥ D2 and positive histopathology ≥ HP1 or positive immunofluorescence ≥F1Mild ELPEndoscopy ≥ D1 and positive histopathology ≥ HP1 and/or positive Immunofluorescence ≥F1OREndoscopy negative but positive histopathology ≥ HP1 and positive Immunofluorescence ≥F1No ELPNone of above criteria met Denudation scoring for SDC D0: No denudation D1: Iatrogenic Denudation (after taking biopsies), D2: Spontaneous localized denudation <1 cm2, D3: Spontaneous extensive denudation >1cm2 Histopathologic scoring for SDC HP0–4 based on total number of following histologic findings: Epithelial detachment, lymphocytic infiltrate, intraepithelial apoptosis (Civatte bodies), Dyskeratosis Immunofluorescence criteria for SDC Fibrinogen deposits along basement graded: F0 = no visible reaction, F1: weak positive, F2: positive Schauer Diagnostic Criteria Denudation scoring for SDC D0: No denudation D1: Iatrogenic Denudation (after taking biopsies), D2: Spontaneous localized denudation <1 cm2, D3: Spontaneous extensive denudation >1cm2 Histopathologic scoring for SDC HP0–4 based on total number of following histologic findings: Epithelial detachment, lymphocytic infiltrate, intraepithelial apoptosis (Civatte bodies), Dyskeratosis Immunofluorescence criteria for SDC Fibrinogen deposits along basement graded: F0 = no visible reaction, F1: weak positive, F2: positive This study aims to evaluate the performance of SDC in diagnosing ELP and stratifying severity for patients with prior extra-esophageal LP manifestations at our center. The original study by Schauer et al excluded patients who had no extra-esophageal manifestations of LP. We expand upon their work by also evaluating SDC’s utility for patients who never developed any extra-esophageal manifestations of LP. METHODS Data collection We identified esophageal biopsies from adult patients (≥18 years) with lichenoid patterns of injury at our tertiary care center between December 2007 and May 2024. A lichenoid pattern was established if the pathology report included the terms ‘lichenoid’ or ‘LP’ as interpreted by the reading pathologist. Our center has no established protocol for biopsy of suspected ELP, so the endoscopic biopsies and subsequent histopathologic assessment were driven by individual physicians. Patients who were being treated for symptoms during endoscopy were included. From the 165 specimens initially identified, 38 were excluded due to missing information or exclusion criteria (concurrent gastrointestinal autoimmune diseases, other known motility disorders, and active malignancies). Aim 1: Evaluating the ability of SDC to diagnose ELP in patients with extra-esophageal LP We included specimens with at least one esophageal biopsy showing lichenoid injury, a documented diagnosis of extra-esophageal LP (cutaneous and/or non-esophageal mucosal manifestation), and available endoscopy and histopathology reports. We extracted demographic information, clinical presentations, endoscopic findings, and histologic features. The SDC was applied to classify disease severity into Severe, Mild, or No ELP categories. Clinic notes were reviewed for ELP diagnosis as assessed by gastroenterologists using clinical information, endoscopic findings, and histologic data. Aim 2: Evaluating the ability of SDC to diagnose ELP in patients without extra-esophageal LP We included specimens with at least one esophageal biopsy showing a lichenoid injury pattern, no documented history of extra-esophageal LP, and available endoscopy and histopathology data. SDC was used to stratify patients into Severe, Mild, or No ELP categories. Clinic notes were reviewed for ELP diagnosis as assessed by gastroenterologists using clinical information, endoscopic findings, and histologic data. RESULTS Cohort with extra-esophageal LP We analyzed 43 biopsies from 17 patients with extra-esophageal LP. The cohort was predominantly female (94%) and white (88.2%). As noted in Table 2, 41% of patients had only mucosal involvement of LP, while 18% had only cutaneous involvement. The remaining 41% had both cutaneous and mucosal involvement. Dysphagia was the most common symptom (94%), followed by heartburn (35%). Odynophagia and food impaction were each reported in 12% of patients. Table 2Demographics and clinical symptoms for cohort with extra-esophageal LPScoring systemSchauer Diagnostic Criteria (SDC)Total (17)Severe ELPMild ELPNo ELPTotal patients17845 Number of patients with ELP diagnosis by a gastroenterologist 8/8 (100%)4/4 (100%)3/5 (60%)Female16/17 (94.1%)8/8 (100%)4/4 (100%)4/5 (80%)Male1/17 (5.9%)0/80/41/5 (20%)White15/17 (88.2%)8/8 (100%)4/4 (100%)3/5 (60%)Black1/17 (5.9%)0/80/41/5 (20%)Asian1/17 (5.9%)0/80/41/5 (20%)Hispanic0/17 (0%)0/80/40/5Non-Hispanic17/17 (100%)8/8 (100%)4/4 (100%)5/5 (100%)Cutaneous LP only3/17 (17.6%)1/8 (12.5%)1/4 (25%)1/5 (20%)Mucosal LP only7/17 (41.2%)3/8 (37.5%)2/4 (50%)2/5 (40%)Mucosal + Cutaneous LP7/17 (41.2%)4/8 (50%)1/4 (25%)2/5 (40%)Dysphagia16/17 (94.1%)8/8 (100%)4/4 (100%)4/5 (80%)Odynophagia2/17 (11.8%)1/8 (25%)0/41/5 (20%)Heartburn6/17 (35.3%)3/8 (37.5%)3/4 (75%)0/5Food impaction2/17 (11.8%)0/82/4 (50%)0/5 Demographics and clinical symptoms for cohort with extra-esophageal LP As noted in Table 3, the most common endoscopic findings were sloughing (79%) and mucosal pallor (74%). Exudates appeared in 21% of endoscopies, and strictures were present in 69%. Erythema and ulcers were rare. Histologically, lymphocytic infiltration and dyskeratosis were noted in all biopsies, while epithelial detachment (12%) and intraepithelial apoptosis (19%) occurred less frequently. Immunofluorescence was performed on eight specimens, with fibrinogen deposits noted in 87.5% of these specimens. Table 3Endoscopic and histologic features for cohort with extra-esophageal LPSchauer Diagnostic Criteria (SDC)FeatureTotal specimens (43)Severe ELP (32)Mild ELP (5)No ELP (6)Mucosal Pallor32/4330/322/50/6Sloughing34/4332/322/50/6Exudate9/438/320/51/6Stricture presence30/4325/324/51/6Erythema4/434/320/50/6Ulcers0/430/320/50/6Histology criteriaEpithelial detachment5/434/321/50/6Lymphocytic infiltration43/4332/325/56/6Intraepithelial apoptosis8/435/322/51/6Dyskeratosis43/4332/325/56/6Immunofluorescence7/85/62/20/0 Endoscopic and histologic features for cohort with extra-esophageal LP As shown in Table 2, the SDC system categorized five patients as non-ELP. Among the remaining patients, SDC classified eight as severe ELP and four as mild ELP. Of the 17 patients, gastroenterologists identified two as non-ELP, and SDC correctly categorized these patients as non-ELP as well. Three patients were identified as ELP by gastroenterologists, but they were identified as non-ELP by SDC. This discrepancy was primarily driven by the lack of denudation on endoscopy, an essential diagnostic feature of SDC. Mucosal pallor was observed in both mild and severe ELP groups, but was absent in the non-ELP group. Exudates were less common overall but appeared more frequently in severe cases. Cohort without prior extra-esophageal LP We analyzed 84 biopsies from 60 patients without any documented extra-esophageal manifestation of LP (Table 4). The majority (62%) were female. Dysphagia was the most common presenting symptom (53/60), followed by heartburn (35/60). Food impaction (8/60) and odynophagia (7/60) were reported less frequently. Table 4Demographics and clinical symptoms for cohort without extra-esophageal LPSchauer Diagnostic Criteria (SDC)Total (60)Severe ELP (11)Mild ELP (14)No ELP (35) Number of patients with ELP diagnosis by a gastroenterologist 7/11 (63.6%)6/14 (42.9%)2/35 (5.7%) Demographics Female379/11 (81.8%)9/14 (64.3%)19/35 (54.3%)Male232/11 (18.1%)5/14 (35.7%)16/35 (45.7%)White358/11 (72.7%)10/14 (71.4%)17/35 (48.6%)Black183/11 (27.3%)2/14 (14.3%)13/35 (37.1%)Other70/112/14 (14.3%)5/35 (14.3%) Symptoms Dysphagia5311/11 (100%)11/14 (78.6%)31/35 (88.6%)Heartburn353/11 (27.3%)7/14 (50%)25/35 (71.4%)Food impaction84/11 (36.4%)2/14 (14.3%)2/35 (5.7%)Odynophagia73/11 (27.3%)2/14 (14.3%)2/35 (5.7%) Demographics and clinical symptoms for cohort without extra-esophageal LP SDC categorized 11 patients as Severe ELP, 14 as Mild ELP, and 35 as No ELP. Among the Severe group, 7 of 11 patients (63.6%) were diagnosed with ELP by gastroenterologists. In the Mild group, 6 of 14 patients (42.9%) were diagnosed with ELP, compared to only 2 of 35 patients (5.7%) in the No ELP category. While dysphagia and heartburn occurred at similar rates in both ELP and non-ELP groups, food impaction and odynophagia were more common in patients with increasing disease severity. Of the 84 biopsies from patients without extra-esophageal diagnosis, 34 (40.5%) were consistent with ELP according to SDC. Sloughing (97%) was the most common endoscopic feature in the ELP group (Table 5). Mucosal pallor was seen in 56% of ELP group biopsies but also in 46% of the non-ELP group. Strictures were present in 56% of ELP cases and 28% of non-ELP cases. Erythema and ulcers were infrequent in both groups. Table 5Endoscopic and histologic features for cohort without extra-esophageal LPSeverity of ELP as calculated by Schauer Diagnostic Criteria (SDC)Total Specimens (84)Severe ELP (13)Mild ELP (21)No ELP (50) Endoscopy features Mucosal Pallor42/846/1313/2123/50Sloughing33/8413/1320/210/50Stricture presence33/847/1312/2114/50Erythema7/842/132/213/50Ulcers4/840/131/213/50 Histology features Epithelial detachment5/844/130/211/50Lymphocytic infiltration82/8412/1321/2149/50Intraepithelial apoptosis24/845/138/2111/50Dyskeratosis60/849/1317/2134/50Immunofluorescence (only done on 10 specimens)7/103/43/31/3 Endoscopic and histologic features for cohort without extra-esophageal LP Lymphocytic infiltration occurred at similar frequencies in both groups. However, intraepithelial apoptosis (38% vs. 22%), dyskeratosis (76% vs. 68%), and epithelial detachment (12% vs. 2%) were all more frequent in the ELP group. Of the ten specimens tested with immunofluorescence, seven showed positive fibrinogen deposits. Six of seven ELP cases had positive immunofluorescence, compared to one of three non-ELP cases. DISCUSSION ELP represents a significant manifestation of the broader LP condition, affecting the digestive tract in numerous individuals who experience esophageal symptoms. There are substantial challenges in identifying this condition, as many of its characteristic features—including endoscopic sloughing and lymphocytic infiltrate on histology —often resemble those of other esophageal disorders. Additionally, ELP can develop without any extra-esophageal involvement. Herein, the SDC scoring system has been developed to help address these diagnostic challenges. In our patient cohort with known extra-esophageal LP, the most frequent endoscopic abnormalities included the classic findings of sloughing, mucosal pallor, and strictures; however, exudates and erythema were also observed. Histologically, all patients demonstrated lymphocytic infiltration and dyskeratosis, while epithelial detachment and intraepithelial apoptosis provided additional diagnostic support in several cases. Direct immunofluorescence, although infrequently performed, was positive in both mild and severe disease. As a diagnostic tool, the SDC demonstrated 82% concordance (14/17) with expert gastroenterologist assessment. The three discordant cases were attributable to the absence of endoscopic denudation, suggesting that this feature may not be essential for diagnosis if other features align with the diagnosis. Assuming gastroenterologist assessment is the gold standard, SDC demonstrates 80% sensitivity and 100% specificity for the cohort with extra-esophageal LP. Overall, our study supports the use of SDC in facilitating the diagnosis of ELP in patients with known extra-esophageal involvement. Notably, our study also identified a sizeable cohort of patients without extra-esophageal LP who exhibited histologic and endoscopic features consistent with ELP (25 of 60 patients). This supports emerging evidence that ELP may occur independently of other extra-esophageal involvement, challenging the traditional reliance on extra-esophageal LP for diagnosis. Among these patients, SDC identified a significant proportion with severe ELP who were correctly diagnosed with ELP by gastroenterologists. However, a notable proportion of cases classified as mild by SDC lacked formal ELP diagnosis by gastroenterologists, suggesting potential underdiagnosis in clinical practice for patients without any extra-esophageal LP. The strengths of this study include its use of a large cohort from a tertiary care center, a rigorous pathology-based case identification process, and systematic application of the diagnostic scoring system. Our work provides a robust evaluation of a scoring system for diagnosing ELP and introduces a novel application of SDC in patients without extra-esophageal involvement, highlighting the potential for missed diagnoses. There are several potential limitations of our study. We evaluate a rare disease from a single tertiary care center, leading to limitations in generalizability. The retrospective design and reliance on existing medical records could introduce bias. We also included patients irrespective of therapeutic intervention, which could potentially affect the endoscopic and histologic findings. Additionally, the lack of standardized endoscopic protocols and standardized histologic assessment may have skewed the data. Future research should focus on prospective validation of SDC across diverse patient populations, ensuring standardized endoscopic and histopathologic evaluation. A multidisciplinary approach involving gastroenterologists and pathologists is essential for refining diagnostic criteria and improving clinical recognition of ELP. Further exploration of immunohistochemical and molecular markers may enhance diagnostic accuracy. Widespread use of immunofluorescence in histopathologic evaluation for ELP could also be beneficial for improving SDC. Additionally, longitudinal studies are needed to assess disease progression, treatment efficacy, and potential complications. In conclusion, our study underscores the need for improved awareness, screening, and standardized diagnostic criteria for ELP. ELP should be on the differential diagnosis for patients with esophageal dysphagia, even in the absence of any extra-esophageal manifestations of LP. Our study supports early use of the SDC for patients with unexplained dysphagia and/or strictures to simplify diagnosis. By refining diagnostic tools like SDC, we can enhance early detection and management, ultimately improving patient outcomes in this under-recognized and morbid condition. Specific author contributions: Anwesh Dash (Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Writing—original draft, Writing—review & editing), Alexandra Strauss Starling (Data curation, Methodology, Writing—review & editing), Sydney Shaffer (Conceptualization, Methodology, Validation), Amanda B Muir (Conceptualization, Methodology, Validation, Writing—review & editing), and Kristle Lee Lynch (Conceptualization, Data curation, Formal analysis, Methodology, Writing—original draft, Writing—review & editing) Financial support: None. Potential competing interests: None. Conflicts of interest: The authors do not have any conflicts of interest to disclose. Contributor Information Anwesh Dash, Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Alexandra Strauss Starling, Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Sydney Shaffer, Department of Pathology and Laboratory Science, Hospital of the University of Pennsylvania, Philadelphia, PA USA. Amanda Muir, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Kristle L Lynch, Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. References